Ahwatukee Behavioral Health & Wellness provides MAT to all qualified clients when deemed medically appropriate by our providers and is offered as a part of a holistic treatment plan to promote abstinence from drugs, alcohol, and other substances of abuse. Ahwatukee Behavioral Health & Wellness offers FDA-approved medications for MAT and evidence-based practices to treat substance abuse and promote abstinence. Our medical providers make a concerted effort to educate clients on the benefits of MAT and provide strong encouragement to engage in MAT to support ongoing abstinence.
Clonidine: A medication used to lessen the moderate symptoms of opioid withdrawal, including sweating, vomiting, chills, and insomnia.
Buprenorphine: An FDA-approved partial opiate antagonist medication used for mild-to-severe opioid use disorder that controls cravings and lessens withdrawal symptoms.
Methadone: A long-acting, full opioid agonist medication used to stabilize and maintain people in recovery from opioid use disorder (OUD).
For the management of acute alcohol withdrawal, benzodiazepines are commonly administered for seizure prophylaxis and other symptomatic management, before being tapered off throughout the detox period.
- With some types of benzodiazepine dependence, a relatively long-acting benzodiazepine (e.g., diazepam, chlordiazepoxide) will first be substituted for the benzodiazepine having been previously used. Then, it will be tapered slowly to ease withdrawal over a more extended amount of time.